ImmuPharma PLC Strategic Asset Allocation Index
ImmuPharma PLC strategic asset allocation index. ImmuPharma PLC (IMM) has a Strategic Asset Allocation Index of 19.2% as of June 2023. Strategic assets (PP&E of GBX332.99K plus long-term investments of GBX-) total GBX332.99K, measured against net assets of GBX1.74 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ImmuPharma PLC balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of ImmuPharma PLC (2006–2021)
Strategic asset allocation index of ImmuPharma PLC from 2006 to 2021. This chart shows how ImmuPharma PLC's Strategic Asset Allocation Index has evolved across 17 annual periods from 2006 to 2021. As of June 2023, the index stands at 19.2%, representing strategic assets of GBX332.99K against net assets of GBX1.74 Million GBX. Check IMM intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
ImmuPharma PLC Strategic Asset Allocation Index by Year (2006–2021)
ImmuPharma PLC strategic asset allocation index by year from 2006 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for ImmuPharma PLC from 2006 to 2021, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ImmuPharma PLC stock valuation.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 8.0% | GBX353.00K | GBX353.00K | GBX- | GBX4.41 Million | ▲ +3.7 pp |
| 2020 | 4.3% | GBX411.61K | GBX411.61K | GBX- | GBX9.65 Million | ▲ +0.3 pp |
| 2019 | 3.9% | GBX206.74K | GBX206.74K | GBX- | GBX5.27 Million | ▼ -24.5 pp |
| 2018 | 28.4% | GBX2.16 Million | GBX164.66K | GBX2.00 Million | GBX7.62 Million | ▲ +23.9 pp |
| 2017 | 4.5% | GBX161.40K | GBX161.40K | GBX- | GBX3.57 Million | ▲ +0.3 pp |
| 2016 | 4.2% | GBX231.90K | GBX231.90K | GBX- | GBX5.55 Million | ▼ -12.4 pp |
| 2015 | 16.6% | GBX280.13K | GBX280.13K | GBX- | GBX1.69 Million | ▲ +10.2 pp |
| 2014 | 6.4% | GBX366.00K | GBX366.00K | GBX- | GBX5.71 Million | ▲ +4.6 pp |
| 2013 | 1.8% | GBX97.00K | GBX97.00K | GBX- | GBX5.40 Million | ▲ +0.4 pp |
| 2012 | 1.4% | GBX115.00K | GBX115.00K | GBX- | GBX8.42 Million | ▲ +0.4 pp |
| 2011 | 1.0% | GBX125.00K | GBX125.00K | GBX- | GBX12.51 Million | ▲ +0.5 pp |
| 2010 | 0.5% | GBX77.00K | GBX77.00K | GBX- | GBX15.97 Million | ▲ +0.4 pp |
| 2009 | 0.0% | GBX9.00K | GBX9.00K | GBX- | GBX18.08 Million | ▼ -0.1 pp |
| 2008 | 0.1% | GBX13.00K | GBX13.00K | GBX- | GBX11.24 Million | ▼ -0.3 pp |
| 2007 | 0.4% | GBX13.00K | GBX13.00K | GBX- | GBX3.05 Million | ▲ +0.2 pp |
| 2006 | 0.2% | GBX12.00K | GBX12.00K | GBX- | GBX5.89 Million | ▼ -0.3 pp |
| 2006 | 0.5% | GBX12.00K | GBX12.00K | GBX- | GBX2.50 Million | — |